Location · Rochester, MN
Clinical trials in Rochester, MN
271 recruiting studies have a site in Rochester, and 115 of them accept healthy volunteers.
271 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 1/Phase 2
A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)
AAVantgarde Bio Srl
- Location
- Rochester, MN + 7 other US sites
- Eligibility basics
- Ages 8–55
- Recruiting
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
Biosense Webster, Inc.
- Location
- Rochester, MN + 22 other US sites
- Eligibility basics
- Ages 22+
- RecruitingPhase 1
NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease
Merida Biosciences
- Location
- Rochester, MN + 10 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis
Atsena Therapeutics Inc.
- Location
- Rochester, MN + 13 other US sites
- Eligibility basics
- Ages 5+
- RecruitingPhase 3
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Vedanta Biosciences, Inc.
- Location
- Rochester, MN + 55 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 3
A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease (NPC)
Azafaros B.V.
- Location
- Rochester, MN + 4 other US sites
- Eligibility basics
- Ages 4+
- Recruiting
Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System
Laplace Interventional, Inc
- Location
- Rochester, MN + 9 other US sites
- Eligibility basics
- Ages 18–90
- RecruitingPhase 2
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
AbbVie
- Location
- Rochester, MN + 53 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults And Adolescent Participants Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)
CorMedix Therapeutics
- Location
- Rochester, MN + 16 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 2/Phase 3
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Janssen Research & Development, LLC
- Location
- Rochester, MN + 53 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
Janssen Research & Development, LLC
- Location
- Rochester, MN + 9 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingPhase 3
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Pfizer
- Location
- Rochester, MN + 69 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis
Azafaros B.V.
- Location
- Rochester, MN + 4 other US sites
- Eligibility basics
- Ages 4+
- RecruitingPhase 1
A Study of SGT-501 Gene Therapy in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
Solid Biosciences Inc.
- Location
- Rochester, MN + 2 other US sites
- Eligibility basics
- Ages 7+
- RecruitingPhase 1/Phase 2
A Study of TSRA-196 in Adults With PiZZ Alpha-1 Antitrypsin Deficiency (AATD)
Tessera Therapeutics, Inc.
- Location
- Rochester, MN + 4 other US sites
- Eligibility basics
- Ages 18–70
- Recruiting
Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF
Axon Therapies, Inc.
- Location
- Rochester, MN + 15 other US sites
- Eligibility basics
- Ages 40+
- Recruiting
TVMR With the INNOVALVE System Trial - Early Feasibility Study
Edwards Lifesciences
- Location
- Rochester, MN + 18 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)
VDyne, Inc.
- Location
- Rochester, MN + 7 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2/Phase 3
Evaluation of the Efficacy and Safety of THRV-1268 in Participants With Long QT Syndrome Type 2 (LQTS2) and Type 3 (LQTS3)
Thryv Therapeutics, Inc.
- Location
- Rochester, MN + 6 other US sites
- Eligibility basics
- Ages 15+
- RecruitingPhase 1/Phase 2
Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
Tr1X, Inc.
- Location
- Rochester, MN + 7 other US sites
- Eligibility basics
- Ages 18–65
- Recruiting
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
JenaValve Technology, Inc.
- Location
- Rochester, MN + 33 other US sites
- Eligibility basics
- Any age listed
- RecruitingPhase 3
A Trial to Assess the Efficacy and Safety of Engasertib in Participants With Moderate to Severe Hereditary Hemorrhagic Telangiectasia (HHT)
Vaderis Therapeutics AG
- Location
- Rochester, MN + 3 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Edwards Lifesciences
- Location
- Rochester, MN + 44 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
Regeneron Pharmaceuticals
- Location
- Rochester, MN + 2 other US sites
- Eligibility basics
- Ages 18–60